vs
Side-by-side financial comparison of Sphere 3D Corp. (ANY) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
Sphere 3D Corp. is the larger business by last-quarter revenue ($2.7M vs $2.2M, roughly 1.2× Instil Bio, Inc.). On growth, Sphere 3D Corp. posted the faster year-over-year revenue change (3.1% vs -19.2%).
Sphere 3D Corp is a global technology company specializing in cloud computing, data management, and virtualization solutions. It delivers enterprise-grade products and services tailored for small to medium-sized businesses, large enterprise clients, and public sector entities, focusing on optimizing IT infrastructure efficiency and cutting operational costs for end users.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
ANY vs TIL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.7M | $2.2M |
| Net Profit | — | $-8.2M |
| Gross Margin | — | — |
| Operating Margin | -372.7% | -426.3% |
| Net Margin | — | -365.3% |
| Revenue YoY | 3.1% | -19.2% |
| Net Profit YoY | — | 31.1% |
| EPS (diluted) | $-6.96 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.7M | $2.2M | ||
| Q3 25 | $2.6M | $2.2M | ||
| Q2 25 | $3.0M | $2.2M | ||
| Q1 25 | $2.8M | $2.2M | ||
| Q4 24 | $2.6M | $2.8M | ||
| Q3 24 | $2.4M | $1.5M | ||
| Q2 24 | $4.7M | $0 | ||
| Q1 24 | $6.9M | $0 |
| Q4 25 | — | $-8.2M | ||
| Q3 25 | $-4.2M | $-13.6M | ||
| Q2 25 | $1.7M | $-21.4M | ||
| Q1 25 | $-8.8M | $-28.2M | ||
| Q4 24 | — | $-11.9M | ||
| Q3 24 | $104.0K | $-23.0M | ||
| Q2 24 | $2.1M | $-14.9M | ||
| Q1 24 | $-4.5M | $-24.3M |
| Q4 25 | — | — | ||
| Q3 25 | 25.4% | — | ||
| Q2 25 | 23.8% | — | ||
| Q1 25 | 22.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -16.0% | — | ||
| Q2 24 | 15.2% | — | ||
| Q1 24 | 38.0% | — |
| Q4 25 | -372.7% | -426.3% | ||
| Q3 25 | -153.8% | -670.0% | ||
| Q2 25 | -87.0% | -1045.5% | ||
| Q1 25 | -184.2% | -1363.2% | ||
| Q4 24 | -328.7% | -426.1% | ||
| Q3 24 | -218.8% | -1582.8% | ||
| Q2 24 | -122.4% | — | ||
| Q1 24 | -26.9% | — |
| Q4 25 | — | -365.3% | ||
| Q3 25 | -162.0% | -606.0% | ||
| Q2 25 | 55.2% | -954.2% | ||
| Q1 25 | -311.9% | -1257.8% | ||
| Q4 24 | — | -428.8% | ||
| Q3 24 | 4.4% | -1541.9% | ||
| Q2 24 | 45.5% | — | ||
| Q1 24 | -64.5% | — |
| Q4 25 | $-6.96 | $-1.13 | ||
| Q3 25 | $-0.15 | $-2.01 | ||
| Q2 25 | $0.06 | $-3.24 | ||
| Q1 25 | $-0.32 | $-4.32 | ||
| Q4 24 | $-4.62 | $-1.82 | ||
| Q3 24 | $0.01 | $-3.54 | ||
| Q2 24 | $0.10 | $-2.29 | ||
| Q1 24 | $-0.27 | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.7M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $23.3M | $113.9M |
| Total Assets | $25.1M | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.7M | $6.6M | ||
| Q3 25 | $5.3M | $5.8M | ||
| Q2 25 | $4.7M | $7.7M | ||
| Q1 25 | $2.8M | $15.4M | ||
| Q4 24 | $5.4M | $8.8M | ||
| Q3 24 | $5.0M | $6.7M | ||
| Q2 24 | $4.3M | $6.8M | ||
| Q1 24 | $9.3M | $5.5M |
| Q4 25 | $23.3M | $113.9M | ||
| Q3 25 | $29.5M | $120.4M | ||
| Q2 25 | $32.7M | $131.7M | ||
| Q1 25 | $30.7M | $144.9M | ||
| Q4 24 | $39.3M | $169.4M | ||
| Q3 24 | $35.8M | $176.3M | ||
| Q2 24 | $33.4M | $195.0M | ||
| Q1 24 | $27.5M | $205.8M |
| Q4 25 | $25.1M | $203.5M | ||
| Q3 25 | $31.1M | $211.8M | ||
| Q2 25 | $34.4M | $231.0M | ||
| Q1 25 | $34.3M | $237.4M | ||
| Q4 24 | $43.2M | $263.6M | ||
| Q3 24 | $44.3M | $272.6M | ||
| Q2 24 | $44.0M | $294.3M | ||
| Q1 24 | $42.0M | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.1M | $-7.1M |
| Free Cash FlowOCF − Capex | $-23.6M | — |
| FCF MarginFCF / Revenue | -867.3% | — |
| Capex IntensityCapex / Revenue | 275.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-40.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.1M | $-7.1M | ||
| Q3 25 | $-3.5M | $-10.6M | ||
| Q2 25 | $-5.8M | $-14.8M | ||
| Q1 25 | $-4.1M | $-4.2M | ||
| Q4 24 | $-4.6M | $-10.6M | ||
| Q3 24 | $290.0K | $-20.1M | ||
| Q2 24 | $-3.3M | $-10.6M | ||
| Q1 24 | $-58.0K | $-14.4M |
| Q4 25 | $-23.6M | — | ||
| Q3 25 | $-5.7M | — | ||
| Q2 25 | $-6.0M | — | ||
| Q1 25 | $-5.1M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $-4.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -867.3% | — | ||
| Q3 25 | -218.7% | — | ||
| Q2 25 | -200.5% | — | ||
| Q1 25 | -181.2% | — | ||
| Q4 24 | -511.9% | — | ||
| Q3 24 | -184.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 275.4% | — | ||
| Q3 25 | 86.5% | — | ||
| Q2 25 | 6.6% | — | ||
| Q1 25 | 36.4% | — | ||
| Q4 24 | 338.7% | 0.0% | ||
| Q3 24 | 196.7% | 0.0% | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -3.51× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.79× | — | ||
| Q2 24 | -1.55× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
